LKB1 tumor suppressor and salt-inducible kinases negatively regulate human T-cell leukemia virus type 1 transcription

Retrovirology

Volumn 10, Issue 1, 2013, Pages

  Tang, Hei Man Vincent ^a   Gao, Wei Wei ^a   Chan, Ching Ping ^a   Siu, Yeung Tung ^a   Wong, Chi Ming ^a   Kok, Kin Hang ^a   Ching, Yick Pang ^a   Takemori, Hiroshi ^b   Jin, Dong Yan ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

Author keywords

Adult T cell leukemia; Human T cell leukemia virus type 1; LKB1 tumor suppressor; Metformin; Salt inducible kinases; Tax oncoprotein

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN REGULATING TRANSCRIPTIONAL COACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PHOSPHOTRANSFERASE; PROTEIN KINASE LKB1; RNA DIRECTED DNA POLYMERASE; SALT INDUCIBLE KINASE; TAX PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL STRAIN HEK293; CONTROLLED STUDY; ENZYME ACTIVATION; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IN VITRO STUDY; LONG TERMINAL REPEAT; MOLECULAR CLONING; NONHUMAN; PLASMID; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; VIRUS TRANSCRIPTION;

CELL LINE; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, TAX; HOST-PATHOGEN INTERACTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION, GENETIC;

HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 84875965249     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-10-40     Document Type: Article

References (54)

1. Matsuoka M, Jeang KT. Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy. Oncogene 2011, 30:1379-1389. 10.1038/onc.2010.537, 3413891, 21119600.
2. Watanabe T. HTLV-1-associated diseases. Int J Hematol 1997, 66:257-278.
3. Iwanaga M, Watanabe T, Utsunomiya A, Okayama A, Uchimaru K, Koh KR, Ogata M, Kikuchi H, Sagara Y, Uozumi K, Mochizuki M, Tsukasaki K, Saburi Y, Yamamura M, Tanaka J, Moriuchi Y, Hino S, Kamihira S, Yamaguchi K. Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan. Blood 2010, 116:1211-1219. 10.1182/blood-2009-12-257410, 20448111.
4. Zhao LJ, Giam CZ. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21-base-pair repeats by protein-protein interaction. Proc Natl Acad Sci USA 1992, 89:7070-7074. 10.1073/pnas.89.15.7070, 49647, 1386673.
5. Semmes OJ, Jeang KT. Definition of a minimal activation domain in human T-cell leukemia virus type I Tax. J Virol 1995, 69:1827-1833. 188792, 7853523.
6. Koga H, Ohshima T, Shimotohno K. Enhanced activation of Tax-dependent transcription of human T-cell leukemia virus type I (HTLV-I) long terminal repeat by TORC3. J Biol Chem 2004, 279:52978-52983. 10.1074/jbc.M409021200, 15466468.
7. Siu YT, Chin KT, Siu KL, Choy EYW, Jeang KT, Jin DY. TORC1 And TORC2 coactivators are required for Tax activation of the human T-cell leukemia virus type 1 long terminal repeats. J Virol 2006, 80:7052-7059. 10.1128/JVI.00103-06, 1489057, 16809310.
8. Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L. The HTLV-1 Tax interactome. Retrovirology 2008, 5:76. 10.1186/1742-4690-5-76, 2533353, 18702816.
9. Simonis N, Rual JF, Lemmens I, Boxus M, Hirozane-Kishikawa T, Gatot JS, Dricot A, Hao T, Vertommen D, Legros S, Daakour S, Klitgord N, Martin M, Willaert JF, Dequiedt F, Navratil V, Cusick ME, Burny A, Van Lint C, Hill DE, Tavernier J, Kettmann R, Vidal M, Twizere JC. Host-pathogen interactome mapping for HTLV-1 and -2 retroviruses. Retrovirology 2012, 9:26. 10.1186/1742-4690-9-26, 3351729, 22458338.
10. Jin DY, Jeang KT. HTLV-I Tax self-association in optimal trans-activation function. Nucleic Acids Res 1997, 25:379-387. 10.1093/nar/25.2.379, 146437, 9016568.
11. Ching YP, Chun AC, Chin KT, Zhang ZQ, Jeang KT, Jin DY. Specific TATAA and bZIP requirements suggest that HTLV-I Tax has transcriptional activity subsequent to the assembly of an initiation complex. Retrovirology 2004, 1:18. 10.1186/1742-4690-1-18, 509288, 15285791.
12. Grassmann R, Aboud M, Jeang KT. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene 2005, 24:5976-5985. 10.1038/sj.onc.1208978, 16155604.
13. Matsuoka M, Green PL. The HBZ gene, a key player in HTLV-1 pathogenesis. Retrovirology 2009, 6:71. 10.1186/1742-4690-6-71, 2731725, 19650892.
14. Hanon E, Hall S, Taylor GP, Saito M, Davis R, Tanaka Y, Usuku K, Osame M, Weber JN, Bangham CR. Abundant Tax protein expression in CD4+ T cells infected with human T-cell lymphotropic virus type I (HTLV-I) is prevented by cytotoxic T lymphocytes. Blood 2000, 95:1386-1392.
15. El Hajj H, El-Sabban M, Hasegawa H, Zaatari G, Ablain J, Saab ST, Janin A, Mahfouz R, Nasr R, Kfoury Y, Nicot C, Hermine O, Hall W, de Thé H, Bazarbachi A. Therapy-induced selective loss of leukemia-initiating activity in murine adult T cell leukemia. J Exp Med 2010, 207:2785-2792. 10.1084/jem.20101095, 3005222, 21135137.
16. Takemori H, Kajimura J, Okamoto M. TORC-SIK cascade regulates CREB activity through the basic leucine zipper domain. FEBS J 2007, 274:3202-3209. 10.1111/j.1742-4658.2007.05889.x, 17565599.
17. Siu YT, Ching YP, Jin DY. Activation of TORC1 transcriptional coactivator through MEKK1-induced phosphorylation. Mol Biol Cell 2008, 19:4750-4761. 10.1091/mbc.E08-04-0369, 2575155, 18784253.
18. Altarejos JY, Montminy M. CREB and the CRTC co-activators: sensors for hormonal and metabolic signals. Nat Rev Mol Cell Biol 2011, 12:141-151. 10.1038/nrm3072, 21346730.
19. Jansen M, Ten Klooster JP, Offerhaus GJ, Clevers H. LKB1 and AMPK family signaling: the intimate link between cell polarity and energy metabolism. Physiol Rev 2009, 89:777-798. 10.1152/physrev.00026.2008, 19584313.
20. Liu Y, Poon V, Sanchez-Watts G, Watts AG, Takemori H, Aguilera G. Salt-inducible kinase is involved in the regulation of corticotropin-releasing hormone transcription in hypothalamic neurons in rats. Endocrinology 2012, 153:223-233. 10.1210/en.2011-1404, 3249682, 22109884.
21. Naoe T, Akao Y, Yamada K, Utsumi KR, Koike K, Shamoto M, Koie K, Kurosawa Y, Kato K, Abe M, Shiku H. Cytogenetic characterization of a T-cell line, ATN-1, derived from adult T-cell leukemia cells. Cancer Genet Cytogenet 1988, 34:77-88. 10.1016/0165-4608(88)90171-9, 3260813.
22. Cereseto A, Diella F, Mulloy JC, Cara A, Michieli P, Grassmann R, Franchini G, Klotman ME. p53 functional impairment and high p21waf1/cip1 expression in human T-cell lymphotropic/leukemia virus type I-transformed T cells. Blood 1996, 88:1551-1560.
23. Michael B, Nair AM, Hiraragi H, Shen L, Feuer G, Boris-Lawrie K, Lairmore MD. Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes. Retrovirology 2004, 1:39. 10.1186/1742-4690-1-39, 538277, 15560845.
24. Lan F, Cacicedo JM, Ruderman N, Ido Y. SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 2008, 283:27628-27635. 10.1074/jbc.M805711200, 2562073, 18687677.
25. Shaw RJ, Kosmatka M, Bardeesy N, Hurley RL, Witters LA, DePinho RA, Cantley LC. The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci USA 2004, 101:3329-3335. 10.1073/pnas.0308061100, 373461, 14985505.
26. Scott KD, Nath-Sain S, Agnew MD, Marignani PA. LKB1 catalytically deficient mutants enhance cyclin D1 expression. Cancer Res 2007, 67:5622-5627. 10.1158/0008-5472.CAN-07-0762, 17575127.
27. Katoh Y, Takemori H, Lin XZ, Tamura M, Muraoka M, Satoh T, Tsuchiya Y, Min L, Doi J, Miyauchi A, Witters LA, Nakamura H, Okamoto M. Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade. FEBS J 2006, 273:2730-2748. 10.1111/j.1742-4658.2006.05291.x, 16817901.
28. Mair W, Morantte I, Rodrigues AP, Manning G, Montminy M, Shaw RJ, Dillin A. Lifespan extension induced by AMPK and calcineurin is mediated by CRTC-1 and CREB. Nature 2011, 470:404-408. 10.1038/nature09706, 3098900, 21331044.
29. Koo SH, Flechner L, Qi L, Zhang X, Screaton RA, Jeffries S, Hedrick S, Xu W, Boussouar F, Brindle P, Takemori H, Montminy M. The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism. Nature 2005, 437:1109-1111. 10.1038/nature03967, 16148943.
30. Wang Z, Takemori H, Halder SK, Nonaka Y, Okamoto M. Cloning of a novel kinase (SIK) of the SNF1/AMPK family from high salt diet-treated rat adrenal. FEBS Lett 1999, 453:135-139. 10.1016/S0014-5793(99)00708-5, 10403390.
31. Takemori H, Okamoto M. Regulation of CREB-mediated gene expression by salt inducible kinase. J Steroid Biochem Mol Biol 2008, 108:287-291. 10.1016/j.jsbmb.2007.09.006, 17935972.
32. Takemori H, Katoh Hashimoto Y, Nakae J, Olson EN, Okamoto M. Inactivation of HDAC5 by SIK1 in AICAR-treated C2C12 myoblasts. Endocr J 2009, 56:121-130. 10.1507/endocrj.K08E-173, 18946175.
33. Al-Hakim AK, Goransson O, Deak M, Toth R, Campbell DG, Morrice NA, Prescott AR, Alessi DR. 14-3-3 cooperates with LKB1 to regulate the activity and localization of QSK and SIK. J Cell Sci 2005, 118:5661-5673. 10.1242/jcs.02670, 16306228.
34. Ahn S, Olive M, Aggarwal S, Krylov D, Ginty DD, Vinson C. A dominant-negative inhibitor of CREB reveals that it is a general mediator of stimulus-dependent transcription of c-fos. Mol Cell Biol 1998, 18:967-977. 108809, 9447994.
35. Screaton RA, Conkright MD, Katoh Y, Best JL, Canettieri G, Jeffries S, Guzman E, Niessen S, Yates JR, Takemori H, Okamoto M, Montminy M. The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector. Cell 2004, 119:61-74. 10.1016/j.cell.2004.09.015, 15454081.
36. Derse D, Mikovits J, Ruscetti F. X-I and X-II open reading frames of HTLV-I are not required for virus replication or for immortalization of primary T-cells in vitro. Virology 1997, 237:123-128. 10.1006/viro.1997.8781, 9344914.
37. Mitchell MS, Bodine ET, Hill S, Princler G, Lloyd P, Mitsuya H, Matsuoka M, Derse D. Phenotypic and genotypic comparisons of human T-cell leukemia virus type 1 reverse transcriptases from infected T-cell lines and patient samples. J Virol 2007, 81:4422-4428. 10.1128/JVI.02660-06, 1900182, 17287279.
38. Shaw RJ, Lamia KA, Vasquez D, Koo SH, Bardeesy N, Depinho RA, Montminy M, Cantley LC. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 2005, 310:1642-1646. 10.1126/science.1120781, 3074427, 16308421.
39. Xie Z, Dong Y, Zhang J, Scholz R, Neumann D, Zou MH. Identification of the serine 307 of LKB1 as a novel phosphorylation site essential for its nucleocytoplasmic transport and endothelial cell angiogenesis. Mol Cell Biol 2009, 29:3582-3596. 10.1128/MCB.01417-08, 2698771, 19414597.
40. Doi J, Takemori H, Lin XZ, Horike N, Katoh Y, Okamoto M. Salt-inducible kinase represses cAMP-dependent protein kinase-mediated activation of human cholesterol side chain cleavage cytochrome P450 promoter through the CREB basic leucine zipper domain. J Biol Chem 2002, 277:15629-15637. 10.1074/jbc.M109365200, 11864972.
41. Conkright MD, Canettieri G, Screaton R, Guzman E, Miraglia L, Hogenesch JB, Montminy M. TORCs: transducers of regulated CREB activity. Mol Cell 2003, 12:413-423. 10.1016/j.molcel.2003.08.013, 14536081.
42. Iourgenko V, Zhang W, Mickanin C, Daly I, Jiang C, Hexham JM, Orth AP, Miraglia L, Meltzer J, Garza D, Chirn GW, McWhinnie E, Cohen D, Skelton J, Terry R, Yu Y, Bodian D, Buxton FP, Zhu J, Song C, Labow MA. Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells. Proc Natl Acad Sci USA 2003, 100:12147-12152. 10.1073/pnas.1932773100, 218727, 14506290.
43. Bittinger MA, McWhinnie E, Meltzer J, Iourgenko V, Latario B, Liu X, Chen CH, Song C, Garza D, Labow M. Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins. Curr Biol 2004, 14:2156-2161. 10.1016/j.cub.2004.11.002, 15589160.
44. Siu YT, Jin DY. CREB - a real culprit in oncogenesis. FEBS J 2007, 274:3224-3232. 10.1111/j.1742-4658.2007.05884.x, 17565603.
45. Tacke F, Liedtke C, Bocklage S, Manns MP, Trautwein C. CREB/PKA sensitive signalling pathways activate and maintain expression levels of the hepatitis B virus pre-S2/S promoter. Gut 2005, 54:1309-1317. 10.1136/gut.2005.065086, 1774645, 15871998.
46. Nishimura S, Asou N, Suzushima H, Okubo T, Fujimoto T, Osato M, Yamasaki H, Lisha L, Takatsuki K. p53 gene mutation and loss of heterozygosity are associated with increased risk of disease progression in adult T cell leukemia. Leukemia 1995, 9:598-604.
47. Bennett WL, Maruthur NM, Singh S, Segal JB, Wilson LM, Chatterjee R, Marinopoulos SS, Puhan MA, Ranasinghe P, Block L, Nicholson WK, Hutfless S, Bass EB, Bolen S. Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations. Ann Intern Med 2011, 154:602-613. 10.7326/0003-4819-154-9-201105030-00336, 21403054.
48. Lee CW, Wong LLY, Tse EYT, Liu HF, Leong VYL, Lee JMF, Hardie DG, Ng IOL, Ching YP. AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res 2012, 72:4394-4404. 10.1158/0008-5472.CAN-12-0429, 3433393, 22728651.
49. Jin DY, Giordano V, Kibler KV, Nakano H, Jeang KT. Role of adapter function in oncoprotein-mediated activation of NF-κB. Human T-cell leukemia virus type I Tax interacts directly with IκB kinase γ. J Biol Chem 1999, 274:17402-17405. 10.1074/jbc.274.25.17402, 10364167.
50. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, Sjostrom SK, Garraway LA, Weremowicz S, Richardson AL, Greulich H, Stewart CJ, Mulvey LA, Shen RR, Ambrogio L, Hirozane-Kishikawa T, Hill DE, Vidal M, Meyerson M, Grenier JK, Hinkle G, Root DE, Roberts TM, Lander ES, Polyak K, Hahn WC. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007, 129:1065-1079. 10.1016/j.cell.2007.03.052, 17574021.
51. Kok KH, Lui PY, Ng MHJ, Siu KL, Au SWN, Jin DY. The double-stranded RNA-binding protein PACT functions as a cellular activator of RIG-I to facilitate innate antiviral response. Cell Host Microbe 2011, 9:299-309. 10.1016/j.chom.2011.03.007, 21501829.
52. Grant C, Oh U, Fugo K, Takenouchi N, Griffith C, Yao K, Newhook TE, Ratner L, Jacobson S. Foxp3 represses retroviral transcription by targeting both NF-κB and CREB pathways. PLoS Pathog 2006, 2:e33. 10.1371/journal.ppat.0020033, 1447668, 16652169.
53. Naderi M, Paryan M, Azadmanesh K, Rafatpanah H, Rezvan H, Mirab Samiee S. Design and development of a quantitative real time PCR assay for monitoring of HTLV-1 provirus in whole blood. J Clin Virol 2012, 53:302-307. 10.1016/j.jcv.2011.12.033, 22306271.
54. Watanabe M, Ohsugi T, Shoda M, Ishida T, Aizawa S, Maruyama-Nagai M, Utsunomiya A, Koga S, Yamada Y, Kamihira S, Okayama A, Kikuchi H, Uozumi K, Yamaguchi K, Higashihara M, Umezawa K, Watanabe T, Horie R. Dual targeting of transformed and untransformed HTLV-1-infected T cells by DHMEQ, a potent and selective inhibitor of NF-κB, as a strategy for chemoprevention and therapy of adult T-cell leukemia. Blood 2005, 106:2462-2471. 10.1182/blood-2004-09-3646, 15956280.